Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2024 17:35 ET | Source: TrueBinding Inc.

TrueBinding Receives FDA IND Go Ahead for Parkinson’s Phase 2A Clinical Trial

TrueBinding cleared an FDA IND application for the BiologicIgG4 antibody neutralizing Galectin-3, TB006, for potential modification of Parkinson's Disease.